
Rohit Ramachandran
· ProfessorRutgers University · Chemical and Biochemical Engineering
Active 1986–2024
About
Rohit Ramachandran is a Professor in the Department of Chemical and Biochemical Engineering at Rutgers University. His research interests encompass process systems engineering, process control, process simulation, process optimization, mathematical modelling, population balance modelling, pharmaceutical engineering, particulate and chemical processes, biological systems, and high-performance computing. He has received numerous honors including the AIChE PD2M Drug Product QbD Award in 2018, the Rutgers Board of Trustees Award for Research Excellence in 2017, and the NSF CAREER Award in 2014. Dr. Ramachandran completed his Ph.D. in Chemical Engineering with a Diploma of Imperial College from Imperial College London, and holds degrees from the National University of Singapore. His professional experience includes positions as Assistant Professor, Associate Professor with tenure, and Professor at Rutgers, along with a postdoctoral associate role at MIT. His work focuses on advancing process engineering through experimental studies, validation, and the development of innovative modelling and control strategies.
Research topics
- Computer Science
- Artificial Intelligence
- Engineering
- Mathematics
- Machine Learning
- Statistics
- Manufacturing engineering
- Chemistry
- Optics
- Biological system
- Chromatography
- Business
- Operations management
- Biochemical engineering
- Data Mining
- Physics
- Process management
- Medicine
- Biotechnology
- Telecommunications
- Risk analysis (engineering)
- Systems engineering
- Reliability engineering
- Mathematical optimization
Selected publications
Optimization of key energy and performance metrics for drug product manufacturing
International Journal of Pharmaceutics · 2022 · 28 citations
- Computer Science
- Process engineering
- Computer Science
Journal of Chemical Technology & Biotechnology · 2021 · 71 citations
- Computer Science
- Manufacturing engineering
- Computer Science
Abstract Continuous bioprocessing is significantly changing the biological drugs (or biologics) manufacturing landscape by potentially improving product quality, process stability, and overall profitability, as was similarly seen during the adoption of advanced manufacturing processes for small molecule drugs in the past decade. However, the implementation of continuous manufacturing for biological processes producing protein‐based drug molecules, such as monoclonal antibodies (mAbs), is facing several new hurdles. The barriers to continuous bioprocessing can be overcome through improved process understanding via better predictive capabilities enabled by hybrid modeling that can also lead to robust process control. This review article summarizes the recent advances and ongoing obstacles faced during the use of advanced process analytical technologies (PAT), process modeling, and control strategies to enable continuous manufacturing of mAbs. In addition, this review also discusses the process strategies and future directions of advanced continuous manufacturing approaches that have been adapted by other industries and that could be implemented for mAbs production soon. © 2021 Society of Chemical Industry (SCI).
International Journal of Pharmaceutics · 2021 · 18 citations
- Computer Science
- Materials science
- Biological system
Journal of Pharmaceutical and Biomedical Analysis · 2021 · 14 citations
- Computer Science
- Artificial Intelligence
- Chemistry
Digital Twins in Pharmaceutical and Biopharmaceutical Manufacturing: A Literature Review
Processes · 2020 · 244 citations
- Computer Science
- Manufacturing engineering
- Artificial Intelligence
The development and application of emerging technologies of Industry 4.0 enable the realization of digital twins (DT), which facilitates the transformation of the manufacturing sector to a more agile and intelligent one. DTs are virtual constructs of physical systems that mirror the behavior and dynamics of such physical systems. A fully developed DT consists of physical components, virtual components, and information communications between the two. Integrated DTs are being applied in various processes and product industries. Although the pharmaceutical industry has evolved recently to adopt Quality-by-Design (QbD) initiatives and is undergoing a paradigm shift of digitalization to embrace Industry 4.0, there has not been a full DT application in pharmaceutical manufacturing. Therefore, there is a critical need to examine the progress of the pharmaceutical industry towards implementing DT solutions. The aim of this narrative literature review is to give an overview of the current status of DT development and its application in pharmaceutical and biopharmaceutical manufacturing. State-of-the-art Process Analytical Technology (PAT) developments, process modeling approaches, and data integration studies are reviewed. Challenges and opportunities for future research in this field are also discussed.
AIChE Journal · 2020 · 43 citations
- Computer Science
- Artificial Intelligence
- Computer Science
Abstract Identification of feasible region of operations in multivariate processes is a problem of interest in several fields. This is particularly challenging when the process model is black‐box in nature and/or is computationally expensive, as analytical solutions are not available and the number of possible model evaluations is limited. An efficient methodology is required to identify samples where the model is evaluated for developing a computationally efficient surrogate model. In this work, an artificial neural network based surrogate model is proposed which is integrated with a statistical‐based approach (Jack‐knifing) to estimate the variance of the surrogate model prediction. This allows implementation of an adaptive sampling approach where new samples are identified close to the feasible region boundary or in regions of high prediction uncertainty. The proposed approach performs better than a previously published kriging based method for different dimensionality case studies.
Recent grants
EAGER:REAL-D: Smart Decision Making using Data and Advanced Modeling Approaches
NSF · $255k · 2018–2023
CAREER: Multi-scale modeling and analysis of reactive granulation processes
NSF · $462k · 2014–2021
Frequent coauthors
- 38 shared
Marianthi Ierapetritou
- 36 shared
Ravendra Singh
Rutgers, The State University of New Jersey
- 27 shared
Fernando J. Muzzio
Rutgers, The State University of New Jersey
- 22 shared
Anwesha Chaudhury
Novartis (United States)
- 21 shared
Lalith Kotamarthy
Rutgers, The State University of New Jersey
- 18 shared
Dana Barrasso
Siemens (United Kingdom)
- 18 shared
František Štěpánek
University of Chemistry and Technology, Prague
- 17 shared
Maitraye Sen
Labs
Awards & honors
- AIChE PD2M Drug Product QbD Award, 2018
- Rutgers Board of Trustees Award for Research Excellence, 201…
- Chancellor’s Scholar Award for Outstanding Scholarship, 2017
- Outstanding CBE Faculty Award, 2015
- CBE Best Teacher/Mentor/Advisor Award, 2015
Similar researchers at Rutgers University
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with Rohit Ramachandran
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup